Published in Cancer Weekly, February 5th, 2008
"We examined whether these functional polymorphisms were related to the risk of nasopharyingeal carcinoma (NPC) in Chinese populations. Eight polymorphisms in the promoter of MMPI, MMP2, MMP3, MMP7, MMP9, MMP12, and MMP13 were genotyped in two independent case-control populations; one is from Guangxi province (593 patients with NPC and 480 controls),...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.